Zoonotic Chlamydophila psittaci infections from a clinical perspective  by Beeckman, D.S.A. & Vanrompay, D.C.G.
Zoonotic Chlamydophila psittaci infections from a clinical perspective
D. S. A. Beeckman and D. C. G. Vanrompay
Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium
Abstract
Human psittacosis is a zoonotic infectious disease which is caused by the obligate intracellular bacterium Chlamydophila psittaci. Trans-
mission of the disease usually originates from close contact with infected birds, most frequently in the context of the poultry industry,
and from contact with Psittaciformes (cockatoos, parrots, parakeets and lories). Due to a low awareness of the disease and a variable
clinical presentation psittacosis is often not recognised as such by general practitioners. This review therefore gives an overview of the
epidemiology, symptoms, diagnosis and possible treatments for psittacosis in humans. The current case deﬁnition for epidemiological
surveillance, as issued by the CDC, is discussed, as well as the possible emergence of Cp. psittaci antibiotic-resistant strains. There is an
urgent need for information and for awareness campaigns directed at professional health care workers and the general public. In addi-
tion, a broader use of new diagnostic methods in medical laboratories and the development of prophylactics are called for.
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Chlamydophila psittaci strain classiﬁcation
Micro-organisms in the family of the Chlamydiaceae are obli-
gate intracellular pathogens of both mammals and birds. The
different species in this family infect many hosts, with variable
tissue tropism causing a multiplicity of acute and chronic
diseases, from sexually transmitted infertility, to trachoma
and respiratory and cardiovascular diseases. Before the
reclassiﬁcation in 1999, the genus Chlamydia (C.) was divided
into only four species: C. trachomatis, C. pecorum, C. pneumo-
niae and C. psittaci. In 1999, Everett et al. [1,2] proposed a
new classiﬁcation after analysis of 16S and 23S rRNA genes,
and phenotypical, morphological and genetic information
(DNA–DNA hybridization). The Chlamydiaceae are currently
divided into two genera, Chlamydia and Chlamydophila (Cp.),
comprising nine species. All known avian strains belong to
the species Cp. psittaci which includes six avian serovars,
designated A–F, and two mammalian isolates (WC and M56)
[3–5]. As the monoclonal antibodies used to distinguish avian
serovars [3,6] are commercially unavailable, analysis of the
MOMP encoding outer membrane protein A gene (ompA) is
today more often used to characterize avian Cp. psittaci
strains into different genotypes. The currently accepted
ompA genotypes (A–F, E/B, M56 and WC) are largely congru-
ent with the serovars and can be distinguished by sequencing
[2], genotype-speciﬁc real-time PCR [7] or micro-arrays [8].
One of the advantages of these molecular techniques is that
they can distinguish among the ompA genotypes E/B, E and B,
which is impossible using serovar-speciﬁc monoclonal anti-
bodies, as genotype E/B reacts with serovar B and serovar E
speciﬁc monoclonals. Moreover, genotype E/B generates the
ompA restriction (AluI) fragment length polymorphism (RFLP)
pattern E [9]. Molecular characterization enables us to deter-
mine phylogenetic relationships among different Cp. psittaci
isolates and even among Cp. psittaci and Cp. abortus strains,
as was previously shown for the abortus-like Cp. psittaci
strain 84/2334, formerly serotyped as serovar A and generat-
ing an ompA genotype F RFLP restriction pattern [5].
The currently known genotypes are relatively host-spe-
ciﬁc. Genotype A and B strains are usually associated with
psittacine birds and pigeons, respectively. Genotype C has
been isolated primarily from ducks and geese, whereas geno-
type D was mainly found in turkeys. Genotype F was isolated
from both a psittacine bird and turkeys. The host range of
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases
REVIEW 10.1111/j.1469-0691.2008.02669.x
genotype E is the most diverse; c. 20% of genotype E strains
were isolated from pigeons. In addition, genotype E was iso-
lated in many fatal cases of chlamydiosis in ratites, during
respiratory outbreaks in ducks and turkeys, and occasionally
from humans. So far, genotype E/B has been isolated mainly
from ducks. WC and M56 are isolates from epizootics in
Wolfsen cattle and muskrats, respectively. All genotypes
should be considered to be readily transmissible to humans
and potentially can cause severe disease and even death.
Epidemiology and transmission
The ﬁrst description of a psittacosis outbreak dates from
1879 and was described by Jacob Ritter, linking the disease
to pet parrots and ﬁnches. Pandemic outbreaks of human
psittacosis in 1929 and 1930 were linked to the import of
infected psittacine birds from South America to Europe and
North America. In the 1930s, isolates from South African
and Californian racing pigeons were also obtained. In the
years that followed, several cases of psittacosis in humans in
New York and California could be attributed to contact with
feral pigeons, ducks and turkeys. Although severe respiratory
outbreaks in the US turkey industry lead to the isolation of
Cp. psittaci from both turkeys and humans in the early 1950s
[10], the incidence of severe Cp. psittaci epidemics in US
poultry declined during the 1960s. Nevertheless, both birds
and humans continued to be exposed to avian chlamydiosis.
During the 1980s and 1990s, psittacosis outbreaks were
reported in the USA [11,12] and European poultry indus-
tries, respectively [13–15]. In the last decade, considerable
evidence indicating that Cp. psittaci is nearly endemic in the
turkey industry in Belgium [16], as well as in other European
countries [16,17], has been obtained. Today, infections in
turkeys seem to induce mild respiratory signs and are not
necessarily fatal. Evidence of human infections associated
with outbreaks in poultry exists [18–26].
Recently, the number of chlamydiosis outbreaks in ducks
and in people in contact with infected ducks has increased
[27] (Laroucau et al., 2009, Veterinary Microbiology, in
press).
Chlamydophila psittaci infections occur in at least 465 bird
species, spanning 30 different bird orders [28]. Especially
Psittacidae (cockatoos, parrots, parakeets and lories) and
Columbiformes (pigeons) seem to be affected. Therefore,
psittacine pet birds, racing pigeons and free-living pigeons in
urban and rural areas throughout the world should be
regarded as the predominant reservoirs of zoonotic psitta-
cosis. Transmission of Cp. psittaci predominantly occurs
through inhalation of contaminated aerosols from urine,
respiratory and eye secretions, or dried faeces from a dis-
eased animal or asymptomatic carrier. Handling the plumage
and tissues of infected birds and, in rare cases, mouth-
to-beak contact or biting, represent a zoonotic risk. In
addition, activities such as gardening and mowing or trim-
ming lawns without a grass catcher have been associated
with human psittacosis, suggesting that these activities
may expose individuals to the infectious agent [29,30].
Person-to-person transmission of psittacosis is possible, but
it is believed to be rare [31,32].
Public health signiﬁcance
The impact of these Cp. psittaci infections on human health
is difﬁcult to determine. In most countries, psittacosis is a
notiﬁable disease and must be reported within 48 h. An
overview of reported cases of psittacosis in several countries
is presented in Table 1. However, these ﬁgures most deﬁ-
nitely represent a gross underestimation of the current num-
ber of infections, as not all infections cause pneumonia and
therefore often remain unnoticed. Moreover, psittacosis is
difﬁcult to diagnose in the wake of empirical therapy for
community-acquired pneumonia [33,34].
Diagnosis of psittacosis
Anamnesis: contact with birds?
A possible explanation for the current underestimation of
the number of cases of psittacosis in humans is that general
practitioners are not necessarily aware of the widespread
occurrence and the zoonotic nature of avian chlamydiosis.
Campaigns to raise awareness, organized by national or local
governments, could increase the general degree of attentive-
ness to human psittacosis. More speciﬁcally, a more thor-
ough enquiry with regards to the patient’s medical history
and professional and leisure occupations could bring contact
with birds to light, thus possibly linking persistent ﬂu-like
symptoms, respiratory distress, fever, chills, headache, weak-
ness or fatigue to human psittacosis.
Clinical presentation
Chlamydophila psittaci mainly causes a respiratory infection in
humans and clinical symptoms are highly variable. After initial
replication in epithelial cells and macrophages from the respi-
ratory system, bacteria might spread throughout the body,
affecting different organs (heart, liver, gastro-intestinal tract).
The incubation period is usually 5–14 days, although periods
up to 1 month have been reported and the disease can vary
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from unapparent, as also recognised by the Centers for Dis-
ease Control (CDC) [35], to fatal in untreated patients [36].
An overview of selected recent case reports is given in
Table 2.
Symptoms frequently include high fever (up to 40.5C)
accompanied by a relatively low pulse, chills, headache, myal-
gia, non-productive coughing and difﬁcult breathing. Occa-
sionally, slimy sputum can be contaminated with traces of
blood. Other symptoms described are non-speciﬁc rash or
gastro-intestinal problems such as vomiting, abdominal pain
and diarrhoea [37]. In rare cases, complications such as myo-
carditis, endocarditis [38], encephalitis [39], icterus [40],
adult respiratory distress syndrome (ARDS) [41] and multi-
organ failure [42] have been described. Among pregnant
women, atypical pneumonia, hepatitis, renal insufﬁciency, sep-
sis, premature birth or foetal death have been observed
(overview in Refs [43,44]). Furthermore, Cp. psittaci has also
been linked to ocular lymphoma, although this is still a mat-
ter of debate [45–48].
Haematology
White cell count is usually normal to slightly lowered during
the acute phase of the disease, developing into leucopoenia
in on average 25% of cases [43]. Anaemia has been observed
secondary to haemolysis, and in patients with overwhelming
infections, disseminated intravascular coagulation may rarely
occur.
Augmented C-reactive protein (CRP), aspartate and ala-
nine aminotransferase or c-glutyl transpeptidase blood
parameters in psittacosis patients and liver enzyme levels
seem to be related to the severity of the infection.
Radiographic ﬁndings
For patients with psittacosis, chest X-rays are abnormal in
up to 90% of hospitalized cases. Most commonly, unilateral,
lower lobe dense consolidation is observed [49], but also
bilateral, nodular, miliary or interstitial inﬁltrates can be pres-
ent [43].
Case deﬁnition
To date, a patient is considered to suffer from human psitta-
cosis if the clinical representation is in concordance with
psittacosis and the case is laboratory conﬁrmed by at least
one of the following methods: (i) isolation of the causative
agent from respiratory secretions, (ii) four-fold or more
increase of antibody titre between paired sera as determined
by a complement ﬁxation test (CFT) or the more sensitive
micro-immunoﬂuorescence (MIF) test or (iii) IgM antibodies
against Cp. psittaci detected by MIF to a reciprocal titre of 16
or more [44]. These case deﬁnitions have been issued by the
CDC for the purpose of epidemiological surveillance, but are
frequently used to diagnose single human cases.
Culture
Isolation of the causative agent during the acute phase of the
infection and before the administration of antimicrobials is
the most reliable method to prove the presence of viable
bacteria in a human (or avian) case of psittacosis. Samples
TABLE 1. Human cases of psittacosis (available data)
Country/territory 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 Notiﬁable
Austria 1 1 2 3 0 3 6
Argentina 38 1
Australia 86 35 55 81 99 137 213 200 239 164 171 62 Yes
Belgium 9 7 8 12 13 10 23 39 12 7 2 3 Yes
Bosnia and Herzegovina 162 0 0 0
Chile 2
Croatia 7 4 0 5 8 3 5 4
Czech Republic 3 5 6 0 3 0 0
Denmark 57* 30 31 8 13 14 8 22 7 11 Yes
Finland 2 1 2 0 0 0 0
F.Y.R. of Macedonia 0 14 0 0 5 0 0
Germany 134 124 155 109 86 56 41 41 15 33 26 12 Yes
Hungary 4 3 4 1 5 1 6 (1) 85 7 140 (2) 29 28 (1) Yes
Japan 23 18 35 54 44 40 34 Yes
New Caledonia 3 3
Poland 2 2 0 2 0 5 2 2
Slovakia 2 0 1 3 10 0 0 1 0 1
Spain 5 4 0 1
Sweden 25 66 30 29 24 12 13 12 7 5 2 9
The Netherlands 56 28 26 25 36 23 17 27 33 49 59 27 Yes
UK/Great Britain 353 322 293 207 204 106 68 100 62 59
UK/N. Ireland 52 37 0 0 44 16 15 13
Ukraine 161 2 3 2 0 0 0 0 0
USA 45 38 54 15 13 19 13 11 Yes
*Number of reported cases from 1996 to 1998.
Number of reported casualties.
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from sputum, pleural ﬂuid or clotted blood can be used for
this purpose. Diagnosis by culture can only be performed in
a limited number of laboratories because of the requirement
of a biosafety level three facility.
In the early days, mainly inoculation into mice and espe-
cially the yolk sac of 6-day-old SPF chicken embryos was per-
formed for primary isolation of the infectious agent. Today,
isolation of Cp. psittaci is routinely performed on cell
cultures, often in the presence of cycloheximide. Numerous
cell types have been described in the literature, such as Buf-
falo Green Monkey (BGM) (Fig. 1), McCoy, HeLa, African
Green Monkey (Vero) and L-929 cells, with BGM cells
shown to be the most sensitive artiﬁcial host [50]. Chlamydo-
phila psittaci growth is usually conﬁrmed by immunoﬂuores-
cence techniques and negative samples are repassaged after
6 days of inoculation, to conﬁrm negative results. Treatment
of the patient with antibiotics or improper handling and
storage of samples may however impair bacterial growth.
Serology
Frequently used serological tests for Cp. psittaci diagnosis in
humans are CFT, ELISA and MIF, which is regarded as the
reference standard. One has to keep in mind however that
detection of anti-chlamydial antibodies, although historically
regarded as highly reliable, is extremely prone to the generation
FIG. 1. Transmission electron microscopy photograph of a Cp. psittaci
infected BGM-cell (5200·). Cells were seeded on a thermanox slide
and inoculated with Cp. psittaci strain 92/1293 for 30 h until ﬁxation.T
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of both false-negative and false-positive results. False-negative
MIF results in ill psittacosis patients have already been
reported [20]. On the other hand, both MIF and CFT use
whole chlamydial organisms to capture antibodies. As some
of the surface-located antigens, such as the chlamydial LPS or
HSP, can cross-react with antibodies to other bacteria [51],
caution is needed when interpreting positive results. To
circumvent this problem, MIF tests and ELISAs using chla-
mydial organisms without the LPS were developed, the latter
being more sensitive than MIF. However, another problem
still remains. None of the current serological tests is Cp.
psittaci-speciﬁc due to serological cross-reaction between
different species of the Chlamydiaceae family, which makes it
difﬁcult to distinguish Cp. psittaci, C. trachomatis and Cp.
pneumoniae antibodies in humans. The case deﬁnitions as
issued by the CDC should therefore not be used as the sole
criteria for reliable diagnosis of human psittacosis.
On the other hand, treatment with antibiotics 2–3 weeks
before testing may inhibit the development of antibodies,
thus generating false-negative results, as is also the case
when patients are sampled before seroconversion.
Molecular detection and characterization
Given the high prevalence of Cp. pneumoniae in man, ranging
from 44% to 66% [52], and the limited discriminatory prop-
erties of serology testing, nucleic-acid based Cp. psittaci-
speciﬁc diagnostic assays targeting highly divergent antigenic
determinants were developed. Multiple nested PCRs based
on ompA detection have been described and are now rou-
tinely being used [53,54]. Moreover, the emergence of
quantitative real-time PCR, sequencing and micro-arrays has
now provided the opportunity to not only conﬁdently
determine the species [7,55], but also the genotype of the
causative agent [7,8,56]. Both the intrinsic sensitivity and
the efﬁciency of the DNA extraction from the clinical sam-
ple are of crucial importance for the sensitivity of the assay.
Particularly, inhibitors of DNA polymerase have to be
removed. However, none of the described nucleic-acid
ampliﬁcation techniques (NAATs) are currently commer-
cially available.
Treatment of Psittacosis Patients
Human cases of psittacosis are preferably treated with tetra-
cyclines, such as doxycycline (100 mg peroral-PO, every 12h-
q12h) or tetracycline hydrochloride (500 mg PO, q6h). In
order to be effective and to prevent relapse, treatment must
continue for at least 10–14 days. In patients for whom tetra-
cycline is contra-indicated (pregnant women) and in children
under 8 years, treatment with macrolides is probably the
best alternative (azithromycin and erythromycin, 250–500 mg
PO qd · 7 days) [44,57]. Tetracyclines and macrolides bind
to 16S or 23S rRNA, respectively, and consequently affect
bacterial translation [58]. Quinolones have been used to
treat chlamydial infections but there have been reports of
treatment failure. To our knowledge, clinical studies on the
effectiveness of quinolones against agents of the Cp. psittaci
group are not yet available. Butaye et al. did however test
the in vitro susceptibilities of 14 avian strains to doxycycline
and enroﬂoxacin. The minimal inhibitory concentration
(MIC) of doxycycline ranged from 0.05 to 0.2 lg/L, while the
MIC of the ﬂuoroquinolone antibiotic was 0.25 lg/L [59],
justifying the choice of tetracyclines rather than quinolones.
Although chlamydial infections can easily be resolved by
treatment with antibiotics and the acquisition of antibiotic
resistance genes from other organisms is limited due to
their obligate intracellular life style, stable tetracycline
resistance through horizontal gene transfer has already
been reported for Chlamydia suis [60,61]. In addition to
the insertion of resistance genes into the bacterial gen-
ome, drug resistance can also arise through point muta-
tions, altering the expression or the functionality of the
antibiotic target [62,63]. As the use of antibiotics, and
especially tetracyclines, is widespread in the poultry and
pet bird industry, resistance to tetracyclines could emerge
among Cp. psittaci strains as well.
Furthermore, treatment with antibiotics might lead to sub-
clinical persistent infections, possibly evolving to chronic dis-
ease and relapse when antibiotics are no longer administered
(for a review, see Ref. [64]).
Conclusion
At present, the presence and zoonotic aspects of Cp. psittaci
are seriously underestimated by the authorities, professional
health care workers and the general public. This is partly
attributable to the rather archaic deﬁnition of human cases
of psittacosis based on serological MIF (cross-reactive, insen-
sitive as compared to ELISA) or CFT (cross-reactive, even
less sensitive than MIF) results. Therefore, criteria deﬁning
human cases of psittacosis should be adapted to include
nucleic-acid ampliﬁcation tests (NAATs), which are Cp. psittac-
i-speciﬁc and extremely sensitive. Psittacosis, whether human
or avian, is currently manageable through administration of
tetracyclines or macrolides. However, as the use of antibiot-
ics is widespread in the poultry and pet bird industry, the
possible emergence of antibiotic resistant zoonotic ﬁeld
strains should be taken into consideration.
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